vs

Side-by-side financial comparison of Dexcom (DXCM) and VEEVA SYSTEMS INC (VEEV). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $811.2M, roughly 1.6× VEEVA SYSTEMS INC). VEEVA SYSTEMS INC runs the higher net margin — 29.1% vs 21.2%, a 7.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 16.0%). Over the past eight quarters, VEEVA SYSTEMS INC's revenue compounded faster (13.4% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud software, data, and business consulting for the life sciences industry. Its software is used to manage data, track regulatory registrations, and oversee supply chains. The company is a public benefit corporation.

DXCM vs VEEV — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.6× larger
DXCM
$1.3B
$811.2M
VEEV
Growing faster (revenue YoY)
DXCM
DXCM
+5.6% gap
DXCM
21.6%
16.0%
VEEV
Higher net margin
VEEV
VEEV
7.9% more per $
VEEV
29.1%
21.2%
DXCM
Faster 2-yr revenue CAGR
VEEV
VEEV
Annualised
VEEV
13.4%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
DXCM
DXCM
VEEV
VEEV
Revenue
$1.3B
$811.2M
Net Profit
$267.3M
$236.2M
Gross Margin
62.9%
75.4%
Operating Margin
25.6%
29.7%
Net Margin
21.2%
29.1%
Revenue YoY
21.6%
16.0%
Net Profit YoY
153.6%
27.1%
EPS (diluted)
$0.67
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
VEEV
VEEV
Q1 26
$1.3B
Q4 25
$1.3B
$811.2M
Q3 25
$1.2B
$789.1M
Q2 25
$1.2B
$759.0M
Q1 25
$1.0B
$720.9M
Q4 24
$1.1B
$699.2M
Q3 24
$994.2M
$676.2M
Q2 24
$1.0B
$650.3M
Net Profit
DXCM
DXCM
VEEV
VEEV
Q1 26
$267.3M
Q4 25
$267.3M
$236.2M
Q3 25
$283.8M
$200.3M
Q2 25
$179.8M
$228.2M
Q1 25
$105.4M
$195.6M
Q4 24
$151.7M
$185.8M
Q3 24
$134.6M
$171.0M
Q2 24
$143.5M
$161.7M
Gross Margin
DXCM
DXCM
VEEV
VEEV
Q1 26
62.9%
Q4 25
62.9%
75.4%
Q3 25
60.5%
75.3%
Q2 25
59.5%
77.1%
Q1 25
56.9%
74.9%
Q4 24
58.9%
75.1%
Q3 24
59.7%
74.8%
Q2 24
62.4%
73.3%
Operating Margin
DXCM
DXCM
VEEV
VEEV
Q1 26
25.6%
Q4 25
25.6%
29.7%
Q3 25
20.1%
24.8%
Q2 25
18.4%
30.8%
Q1 25
12.9%
26.1%
Q4 24
17.0%
25.9%
Q3 24
15.3%
24.6%
Q2 24
15.7%
23.9%
Net Margin
DXCM
DXCM
VEEV
VEEV
Q1 26
21.2%
Q4 25
21.2%
29.1%
Q3 25
23.5%
25.4%
Q2 25
15.5%
30.1%
Q1 25
10.2%
27.1%
Q4 24
13.6%
26.6%
Q3 24
13.5%
25.3%
Q2 24
14.3%
24.9%
EPS (diluted)
DXCM
DXCM
VEEV
VEEV
Q1 26
$0.67
Q4 25
$0.67
$1.40
Q3 25
$0.70
$1.19
Q2 25
$0.45
$1.37
Q1 25
$0.27
$1.17
Q4 24
$0.37
$1.13
Q3 24
$0.34
$1.04
Q2 24
$0.35
$0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
VEEV
VEEV
Cash + ST InvestmentsLiquidity on hand
$917.7M
$1.7B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$7.0B
Total Assets
$6.3B
$8.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
VEEV
VEEV
Q1 26
$917.7M
Q4 25
$917.7M
$1.7B
Q3 25
$1.8B
$1.9B
Q2 25
$1.2B
$2.0B
Q1 25
$904.9M
$1.1B
Q4 24
$606.1M
$1.0B
Q3 24
$621.2M
$1.2B
Q2 24
$939.2M
$1.2B
Stockholders' Equity
DXCM
DXCM
VEEV
VEEV
Q1 26
$2.7B
Q4 25
$2.7B
$7.0B
Q3 25
$2.7B
$6.6B
Q2 25
$2.6B
$6.2B
Q1 25
$2.3B
$5.8B
Q4 24
$2.1B
$5.5B
Q3 24
$2.0B
$5.2B
Q2 24
$2.4B
$4.9B
Total Assets
DXCM
DXCM
VEEV
VEEV
Q1 26
$6.3B
Q4 25
$6.3B
$8.1B
Q3 25
$7.5B
$8.0B
Q2 25
$7.3B
$7.8B
Q1 25
$6.8B
$7.3B
Q4 24
$6.5B
$6.5B
Q3 24
$6.4B
$6.3B
Q2 24
$6.8B
$6.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
VEEV
VEEV
Operating Cash FlowLast quarter
$192.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.82×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
VEEV
VEEV
Q1 26
Q4 25
$294.0M
$192.8M
Q3 25
$659.9M
$238.4M
Q2 25
$303.0M
$877.2M
Q1 25
$183.8M
$69.5M
Q4 24
$301.4M
$164.1M
Q3 24
$199.5M
$92.9M
Q2 24
$279.4M
$763.5M
Free Cash Flow
DXCM
DXCM
VEEV
VEEV
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
DXCM
DXCM
VEEV
VEEV
Q1 26
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
DXCM
DXCM
VEEV
VEEV
Q1 26
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
DXCM
DXCM
VEEV
VEEV
Q1 26
Q4 25
1.10×
0.82×
Q3 25
2.33×
1.19×
Q2 25
1.69×
3.84×
Q1 25
1.74×
0.36×
Q4 24
1.99×
0.88×
Q3 24
1.48×
0.54×
Q2 24
1.95×
4.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

VEEV
VEEV

Subscription Services Veeva Research And Development$364.8M45%
Subscription Services Veeva Commercial Cloud$317.6M39%
Professional Services Veeva Research And Development$81.3M10%
Professional Services Veeva Commercial Cloud$47.5M6%

Related Comparisons